Insider Trading Activity Dova Pharmacuet (NASDAQ:DOVA) – Director Bought 20,169 shares of Stock

ME Staff
-
0

Insider Trading Activity For Dova Pharmacuet (NASDAQ:DOVA)

Steven M Goldman , Director of Dova Pharmacuet (NASDAQ:DOVA) reportedly Bought 20,169 shares of the company’s stock at an average price of 22.23 for a total transaction amount of $448,356.87 SEC Form

Insider Trading History For Dova Pharmacuet (NASDAQ:DOVA)

  • On 7/5/2017 Steven M Goldman, Director, bought 72,000 with an average share price of $17.94 per share and the total transaction amounting to $1,291,680.00.View SEC Filing
  • On 7/5/2017 Lee F Md Phd Allen, Insider, bought 3,500 with an average share price of $17.00 per share and the total transaction amounting to $59,500.00.View SEC Filing
  • On 7/5/2017 Kevin Laliberte, VP, bought 6,200 with an average share price of $17.00 per share and the total transaction amounting to $105,400.00.View SEC Filing
  • On 7/5/2017 Alex Sapir, CEO, bought 20,100 with an average share price of $17.00 per share and the total transaction amounting to $341,700.00.View SEC Filing
  • On 8/15/2017 Steven M Goldman, Director, bought 20,169 with an average share price of $22.23 per share and the total transaction amounting to $448,356.87.View SEC Filing
  • On 8/16/2017 Paul B Manning, Director, bought 25,870 with an average share price of $22.30 per share and the total transaction amounting to $576,901.00.View SEC Filing

    • Analyst Ratings For Dova Pharmacuet (NASDAQ:DOVA)
    These are 1 Hold Rating, 2 Buy Ratings .
    The current consensus rating for Dova Pharmacuet (NASDAQ:DOVA) is Buy (Score: 2.67) with a consensus target price of $29.67 , a potential (15.75% upside)

    Analyst Ratings History For Dova Pharmacuet (NASDAQ:DOVA)

    • On 7/24/2017 Jefferies Group LLC Initiated Coverage of rating Buy to Buy with a price target of $30.00
    • On 7/24/2017 Leerink Swann Initiated Coverage of rating Mkt Perform to Market Perform with a price target of $24.00
    • On 7/24/2017 J P Morgan Chase & Co Initiated Coverage of rating Overweight to Overweight with a price target of $35.00

    Recent Trading Activity for Dova Pharmacuet (NASDAQ:DOVA)
    Shares of Dova Pharmacuet closed the previous trading session at 25.63 down -0.58 -2.21% with 89,562 shares trading hands.